Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Amany Keruakous"'
Publikováno v:
Hematology Reports, Vol 15, Iss 4, Pp 592-596 (2023)
Mantle cell lymphoma (MCL) is an intermediate-grade B-cell lymphoma, representing 2.8% of all non-Hodgkin lymphomas in the US. It is associated with t(11;14)(q13; q23), which leads to the overexpression of cyclin D1, consequently promoting cell proli
Externí odkaz:
https://doaj.org/article/6fe6d0037c6b42cda306d317747fd46e
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Pegylated (PEG)-asparaginase is an established treatment for acute lymphoblastic leukemias that exhibits an antitumor effect by depleting asparagine, an amino acid essential for leukemia cell protein synthesis. Pancreatitis with hypertriglyceridemia
Externí odkaz:
https://doaj.org/article/12980562b1314a09a39958a0e5c03c5a
Autor:
Akshee Batra, Justin Swaby, Priyanka Raval, Haidong Zhu, Neal Lee Weintraub, Martha Terris, Nagla Abdel Karim, Amany Keruakous, David Gutterman, Kirsten Beyer, Melinda Stolley, Sherry-Ann Brown, Avirup Guha
Publikováno v:
COVID. 2:350-368
The Coronavirus Disease 2019 (COVID-19) is a world-wide health crisis on a scale that has not been witnessed in modern times. Socio-economic (SE) factors impact every facet of human existence, including lifestyle, which significantly affects health-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62e276f55c0529c4c8b08c1817e7bc4a
https://doi.org/10.3390/covid2030024
https://doi.org/10.3390/covid2030024
Autor:
Azra Borogovac, Amany Keruakous, Michelle Bycko, Jennifer Holter Chakrabarty, Sami Ibrahimi, Mohamad Khawandanah, George B. Selby, Carrie Yuen, Sarah Schmidt, Marcus T. Autry, Taha Al-Juhaishi, Matthew J. Wieduwilt, Adam S. Asch
Publikováno v:
Bone marrow transplantation. 57(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b43b95826ac85e5ff9109f018a4ebba9
https://pubmed.ncbi.nlm.nih.gov/35411106
https://pubmed.ncbi.nlm.nih.gov/35411106
Autor:
Vamsi Kota, Locke Bryan, Ayushi Chauhan, Mohammed Mian, Amany Keruakous, Jorge Cortes, Anand Jillella
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S445
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af035c1ac7071b3227e9b78846276470
https://doi.org/10.1016/s2152-2650(22)01668-8
https://doi.org/10.1016/s2152-2650(22)01668-8
Autor:
Vamsi Kota, Tahiya Anwar, Sean Malhotra, Tahsin Anwar, Mohammad Anwar, Sarah Jimenez, Courtney Corley, Kimberly Green, Gita Giddens, Courtney Worthington, Kerrie Harmon, Rachel Ashley, Irina Shishkina, Ayushi Chauhan, Amany Keruakous, Ravindra Kolhe, Natasha Savage, Andrea Clarke, Amber B. Clemmons, Jorge E. Cortes, Locke J Bryan, Anand P Jillella
Publikováno v:
Transplantation and Cellular Therapy. 28:S482-S483
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e76fc7e381497db58b9ec401cfc29264
https://doi.org/10.1016/s2666-6367(22)00793-x
https://doi.org/10.1016/s2666-6367(22)00793-x
Autor:
Anand Jillella, Mohammad A.H. Mian, Amany Keruakous, Jorge Cortes, Ayushi Chauhan, Locke Bryan, Laura Walker, Molly James, Vamsi Kota
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::125e340e13fc0681a3f263c19b82b831
https://doi.org/10.1016/s2152-2650(22)00470-0
https://doi.org/10.1016/s2152-2650(22)00470-0
Publikováno v:
Journal of Clinical Oncology. 38:e19542-e19542
e19542 Background: Venetoclax in combination with hypomethylating agents (HMAs) has become standard management for newly diagnosed older and unfit acute myeloid leukemia (AML) patients and an option for relapsed/refractory disease in cases unfit for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31733bbd6782f11c94eae2a813cdffa5
https://doi.org/10.1200/jco.2020.38.15_suppl.e19542
https://doi.org/10.1200/jco.2020.38.15_suppl.e19542
Publikováno v:
Journal of Clinical Oncology. 38:e20507-e20507
e20507 Background: Achievement of response to less than very good partial response (VGPR) after initial induction is an adverse prognostic factor for progression free survival (PFS) in multiple myeloma (MM). Triplet regimen has been demonstrated to b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::076da9e910fb0b1e7da57a48f51cc8ba
https://doi.org/10.1200/jco.2020.38.15_suppl.e20507
https://doi.org/10.1200/jco.2020.38.15_suppl.e20507